EstroGel 0.06% 1.25 g per day is the single approved dose for the treatment of moderate to severe vasomotor symptoms due to menopause. The lowest effective dose of EstroGel 0.06% for this indication has not been determined. Before using the canister for the first time, it …

ESTROGEL® 0.06% (estradiol gel) 2 ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures,...

Apr 15, 2024 · EstroGel package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

EstroGel [package insert]. Morristown, NJ: ASCEND Therapeutics; 2023. 2. Food and Drug Administration. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms—recommendations for clinical evaluation. Draft guidance. Washington, DC; US Department of Health and Human Services; January 2003.

ESTROGEL® (17β-estradiol) is indicated for: replacement therapy in naturally occurring or surgically induced estrogen deficiency states associated with menopausal and postmenopausal symptoms, e.g. hot flushes, sleep disturbances and atrophic vaginitis. ESTROGEL® should be prescribed with an appropriate dosage of progestin for women with

Estrogel transdermal gel is a clear, colourless gel with an odour of alcohol. Hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women. The experience treating women older than 65 years is limited.

Mar 25, 2024 · EstroGel 0.06% 1.25 g per day is the single approved dose for the treatment of moderate to severe vasomotor symptoms due to menopause. The lowest effective dose of EstroGel 0.06% for this indication has not been determined. Before using the canister for the first time, it must be primed.

ESTROGEL is used for replacement of estrogen in menopausal women with symptoms of menopause, which may include hot flushes, disturbed sleep and vaginal dryness. ESTROGEL should not be used by women who have not had a hysterectomy (surgical removal of the uterus) unless it is taken with a progestin medication. ESTROGEL does not contain progestins.

For a complete listing, see the DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING section of the product monograph. Liver dysfunction or disease as long as liver function tests have failed to return to normal. Known or suspected estrogen-dependent or progestin-dependent malignant neoplasia (e.g. endometrial cancer). Endometrial hyperplasia.

EstroGel ® 0.06% is approved by the FDA for use after menopause to reduce moderate to severe hot flashes and to treat moderate to severe menopausal changes in and around the vagina.